197 related articles for article (PubMed ID: 20890305)
21. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation.
Chadee DN; Kyriakis JM
Nat Cell Biol; 2004 Aug; 6(8):770-6. PubMed ID: 15258589
[TBL] [Abstract][Full Text] [Related]
22. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
[TBL] [Abstract][Full Text] [Related]
23. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
[TBL] [Abstract][Full Text] [Related]
24. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
25. Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.
Blessing NA; Kasturirangan S; Zink EM; Schroyer AL; Chadee DN
Cell Signal; 2017 Nov; 39():66-73. PubMed ID: 28757353
[TBL] [Abstract][Full Text] [Related]
26. The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.
Zhou L; Lyons-Rimmer J; Ammoun S; Müller J; Lasonder E; Sharma V; Ercolano E; Hilton D; Taiwo I; Barczyk M; Hanemann CO
Oncogene; 2016 Jun; 35(26):3443-53. PubMed ID: 26549023
[TBL] [Abstract][Full Text] [Related]
27. TRAF2-MLK3 interaction is essential for TNF-alpha-induced MLK3 activation.
Sondarva G; Kundu CN; Mehrotra S; Mishra R; Rangasamy V; Sathyanarayana P; Ray RS; Rana B; Rana A
Cell Res; 2010 Jan; 20(1):89-98. PubMed ID: 19918265
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of merlin regulates its stability and tumor suppressive activity.
Ye K
Cell Adh Migr; 2007; 1(4):196-8. PubMed ID: 19262146
[TBL] [Abstract][Full Text] [Related]
29. Role of MLK3 in the regulation of mitogen-activated protein kinase signaling cascades.
Brancho D; Ventura JJ; Jaeschke A; Doran B; Flavell RA; Davis RJ
Mol Cell Biol; 2005 May; 25(9):3670-81. PubMed ID: 15831472
[TBL] [Abstract][Full Text] [Related]
30. Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.
Zhan Y; Abi Saab WF; Modi N; Stewart AM; Liu J; Chadee DN
Exp Cell Res; 2012 Aug; 318(14):1641-8. PubMed ID: 22652451
[TBL] [Abstract][Full Text] [Related]
31. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
32. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
Rong R; Tang X; Gutmann DH; Ye K
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
[TBL] [Abstract][Full Text] [Related]
33. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
34. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
35. MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
Schroyer AL; Stimes NW; Abi Saab WF; Chadee DN
Oncogene; 2018 Feb; 37(8):1031-1040. PubMed ID: 29084209
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
Mishra R; Barthwal MK; Sondarva G; Rana B; Wong L; Chatterjee M; Woodgett JR; Rana A
J Biol Chem; 2007 Oct; 282(42):30393-405. PubMed ID: 17711861
[TBL] [Abstract][Full Text] [Related]
37. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis.
Xu Z; Maroney AC; Dobrzanski P; Kukekov NV; Greene LA
Mol Cell Biol; 2001 Jul; 21(14):4713-24. PubMed ID: 11416147
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6.
Korchnak AC; Zhan Y; Aguilar MT; Chadee DN
Cell Signal; 2009 Nov; 21(11):1620-5. PubMed ID: 19586614
[TBL] [Abstract][Full Text] [Related]
39. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells.
Kim KY; Kim BC; Xu Z; Kim SJ
J Biol Chem; 2004 Jul; 279(28):29478-84. PubMed ID: 15069087
[TBL] [Abstract][Full Text] [Related]
40. MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice.
Zou W; Greenblatt MB; Shim JH; Kant S; Zhai B; Lotinun S; Brady N; Hu DZ; Gygi SP; Baron R; Davis RJ; Jones D; Glimcher LH
J Clin Invest; 2011 Nov; 121(11):4383-92. PubMed ID: 21965325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
